Oaktree Acquisition Corp. III Life Sciences (OACC) Total Current Liabilities (2024 - 2026)
Oaktree Acquisition Corp. III Life Sciences filings provide 3 years of Total Current Liabilities readings, the most recent being $1.6 million for Q1 2026.
- Quarterly Total Current Liabilities rose 53.44% to $1.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Mar 2026, up 53.44% year-over-year, with the annual reading at $1.3 million for FY2025, 78.69% up from the prior year.
- Total Current Liabilities hit $1.6 million in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, up from $1.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.6 million in Q1 2026 and bottomed at $727323.0 in Q4 2024.
- Average Total Current Liabilities over 3 years is $1.2 million, with a median of $1.2 million recorded in 2025.
- The largest annual shift saw Total Current Liabilities skyrocketed 78.69% in 2025 before it soared 53.44% in 2026.
- Oaktree Acquisition Corp. III Life Sciences' Total Current Liabilities stood at $727323.0 in 2024, then soared by 78.69% to $1.3 million in 2025, then rose by 24.97% to $1.6 million in 2026.
- Per Business Quant, the three most recent readings for OACC's Total Current Liabilities are $1.6 million (Q1 2026), $1.3 million (Q4 2025), and $1.2 million (Q3 2025).